Clinical & Experimental Metastasis

Papers
(The H4-Index of Clinical & Experimental Metastasis is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis107
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics51
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches49
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma44
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models28
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption23
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics22
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression21
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria21
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection19
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG19
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss19
Oncolytic intralesional therapy for metastatic melanoma19
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review18
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression17
Axillary nodal staging in breast cancer: what have we learned?17
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions17
0.18444180488586